Table of Contents

company-logo

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Xenetic Biosciences Dividend Announcement

• Xenetic Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Xenetic Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Xenetic Biosciences Dividend History

Xenetic Biosciences Dividend Yield

Xenetic Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Xenetic Biosciences stock? Use our calculator to estimate your expected dividend yield:

Xenetic Biosciences Financial Ratios

P/E ratio-1.64
PEG ratio-1.57
P/B ratio0.95
ROE-49.49%
Payout ratio0.00%
Current ratio6.96
Quick ratio6.96
Cash Ratio6.78

Xenetic Biosciences Dividend FAQ

Does Xenetic Biosciences stock pay dividends?
Xenetic Biosciences does not currently pay dividends to its shareholders.
Has Xenetic Biosciences ever paid a dividend?
No, Xenetic Biosciences has no a history of paying dividends to its shareholders. Xenetic Biosciences is not known for its dividend payments.
Why doesn't Xenetic Biosciences pay dividends?
There are several potential reasons why Xenetic Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Xenetic Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Xenetic Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Xenetic Biosciences a dividend aristocrat?
Xenetic Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Xenetic Biosciences a dividend king?
Xenetic Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Xenetic Biosciences a dividend stock?
No, Xenetic Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Xenetic Biosciences stocks?
To buy Xenetic Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Xenetic Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.